XOMA Royalty (XOMA) Long-Term Investments (2018 - 2022)

XOMA Royalty's (XOMA) quarterly Long-Term Investments came in at $500000.0 in Q1 2022, down 37.5% year-on-year from $800000.0 in Q1 2021, and down 37.5% quarter-over-quarter from $800000.0 in Q4 2021.

XOMA Royalty (XOMA) Long-Term Investments (2018 - 2022) Analysis & Trends

XOMA Royalty has disclosed Long-Term Investments across 5 years of filings, most recently posting $500000.0 for Q1 2022.

  • Long-Term Investments for Q1 2022 came in at $500000.0, down 37.5% year-over-year; the trailing twelve-month figure through Mar 2022 was $500000.0 (down 37.5% YoY), and the FY2021 annual result was $800000.0, down 52.75% from the prior year.
  • Long-Term Investments came in at $500000.0 for Q1 2022 at XOMA Royalty, down from $800000.0 in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $2.6 million in Q3 2020 to a low of $347000.0 in Q3 2018.
  • The 5-year median for Long-Term Investments is $800000.0 (2021), against an average of $993437.5.
  • Across the five-year window, Long-Term Investments plunged 63.14% in 2020 and jumped 333.15% in 2021, its largest moves.
  • XOMA Royalty's Long-Term Investments stood at $392000.0 in 2018, then jumped by 73.72% to $681000.0 in 2019, then soared by 148.6% to $1.7 million in 2020, then sank by 52.75% to $800000.0 in 2021, then plunged by 37.5% to $500000.0 in 2022.
  • The last three Long-Term Investments figures came in at $500000.0 (Q1 2022), $800000.0 (Q4 2021), and $1.2 million (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 5.17 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 5.75 Bn
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2022 500,000.00
Dec 31, 2021 800,000.00
Sep 30, 2021 1.20 Mn
Jun 30, 2021 2.30 Mn
Mar 31, 2021 800,000.00
Dec 31, 2020 1.69 Mn
Sep 30, 2020 2.57 Mn
Jun 30, 2020 531,000.00
Mar 31, 2020 408,000.00
Dec 31, 2019 681,000.00
Sep 30, 2019 873,000.00
Jun 30, 2019 1.14 Mn
Mar 31, 2019 1.11 Mn
Dec 31, 2018 392,000.00
Sep 30, 2018 347,000.00
Jun 30, 2018 553,000.00